AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8754401 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 29691288 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 6204142 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29713133 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 31431562 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 23362174 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21372569 — Biomarker: TMPRSS11D mRNA
Type: Predictive Biomarker (PRD)
Genes: TMPRSS11D; HAT
Study 25872610 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25872610 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 16828295 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 7900628 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 30702517 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 26678938 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16688094 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 9255270 — Biomarker: Lactate dehydrogenase
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 9255270 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 9255270 — Biomarker: Serum sodium
Type: Surrogate Endpoint (SUR)
Study 8510386 — Biomarker: Free fatty acids
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 29476677 — Biomarker: CAT mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CAT
Study 18624972 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 25002161 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 11577951 — Biomarker: Complement C3
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: C3; CPAMD1
Study 8051381 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 31997704 — Biomarker: Arginine vasopressin
Type: Predictive Biomarker (PRD)
Genes: AVP; ARVP; VP
Study 31958773 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31958773 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 17093248 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 9506734 — Biomarker: SI mRNA
Type: Predictive Biomarker (PRD)
Genes: SI
Study 30466306 — Biomarker: SPN mRNA
Type: Predictive Biomarker (PRD)
Genes: SPN; CD43
Study 29343693 — Biomarker: SI mRNA
Type: Predictive Biomarker (PRD)
Genes: SI
Study 11882468 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 8574231 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 2278377 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28272228 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 24713310 — Biomarker: CPM mRNA
Type: Predictive Biomarker (PRD)
Genes: CPM
Study 22797188 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 20680681 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study 20680681 — Biomarker: Vascular endothelial growth factor receptor 2
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY)
Genes: KDR; FLK1; VEGFR2
Study 20680681 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 20680681 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 9718289 — Biomarker: Homovanillic acid
Type: Pharmacodynamic Biomarker (PDY)
Study 19187616 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16306073 — Biomarker: DPT mRNA
Type: Predictive Biomarker (PRD)
Genes: DPT
Study 12201832 — Biomarker: Hormone receptor
Type: Predictive Biomarker (PRD)
Study 12201832 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 24316262 — Biomarker: IFNL3 mRNA
Type: Predictive Biomarker (PRD)
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study 24281396 — Biomarker: GAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAD1; GAD; GAD67
Study 3215041 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28508306 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25103271 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 12827224 — Biomarker: ASRGL1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ASRGL1; ALP; CRASH
Study 12827224 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 7963512 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16361671 — Biomarker: OTOR mRNA
Type: Predictive Biomarker (PRD)
Genes: OTOR; FDP; MIAL; UNQ3054/PRO9873
Study 16361671 — Biomarker: ITSN2 mRNA
Type: Predictive Biomarker (PRD)
Genes: ITSN2; KIAA1256; SH3D1B; SWAP
Study 25302624 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 21663632 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 16684702 — Biomarker: Auditory steady-state response
Type: Pharmacodynamic Biomarker (PDY)
Study 24500540 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 27731374 — Biomarker: CD28 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD28
Study 27731374 — Biomarker: Mitochondrial membrane potential
Type: Pharmacodynamic Biomarker (PDY)
Study 27731374 — Biomarker: Succinate dehydrogenase
Type: Safety Biomarker (SAF)
Genes: SDHD
Study 15562385 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 15562385 — Biomarker: Serum alkaline phosphatase
Type: Surrogate Endpoint (SUR)
Study 8558148 — Biomarker: COMT mRNA
Type: Predictive Biomarker (PRD)
Genes: COMT
Study 8558148 — Biomarker: DDC mRNA
Type: Predictive Biomarker (PRD)
Genes: DDC; AADC
Study 3931495 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27618854 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 26195199 — Biomarker: PPP1R13L mRNA
Type: Predictive Biomarker (PRD)
Genes: PPP1R13L; IASPP; NKIP1; PPP1R13BL; RAI
Study 20529333 — Biomarker: ALPK3 mRNA
Type: Predictive Biomarker (PRD)
Genes: ALPK3; KIAA1330; MAK
Study 12814389 — Biomarker: Cystatin C
Type: Safety Biomarker (SAF)
Genes: CST3
Study 31610946 — Biomarker: DAP mRNA
Type: Predictive Biomarker (PRD)
Genes: DAP; DAP1
Study 26297055 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 25599775 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 19067673 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 19067673 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 17985060 — Biomarker: CD55 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD55; CR; DAF
Study 15784478 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 11860726 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 7576678 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 30318190 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 8582220 — Biomarker: PVR mRNA
Type: Predictive Biomarker (PRD)
Genes: PVR; PVS
Study 43255 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21851353 — Biomarker: Vitamin D-binding protein
Type: Predictive Biomarker (PRD)
Genes: GC
Study 20706107 — Biomarker: Cervical intraepithelial neoplasia
Type: Surrogate Endpoint (SUR)
Study 11936532 — Biomarker: Cyclic adenosine monophosphate
Type: Pharmacodynamic Biomarker (PDY)
Study 10464004 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26275480 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 16768837 — Biomarker: FOS mRNA
Type: Predictive Biomarker (PRD)
Genes: FOS; G0S7
Study 15606633 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 9539303 — Biomarker: Serum testosterone
Type: Surrogate Endpoint (SUR)
Study 19015347 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 16785153 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study 16785153 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 16785153 — Biomarker: Serum luteinizing hormone
Type: Surrogate Endpoint (SUR)
Study 9423751 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 3310771 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 21858735 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2059396 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24457632 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 30504569 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 30504569 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 30504569 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 30504569 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 20619837 — Biomarker: PCSK9 mRNA
Type: Predictive Biomarker (PRD)
Genes: PCSK9; NARC1; PSEC0052
Study 12895320 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 29266804 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 29266804 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29266804 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 22434523 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 8668568 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 8668568 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29887537 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 27941179 — Biomarker: Free fatty acids
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 24561815 — Biomarker: PGC mRNA
Type: Predictive Biomarker (PRD)
Genes: PGC
Study 24561815 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 22585532 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 22585532 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 22585532 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 6777109 — Biomarker: Free fatty acids
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 28209343 — Biomarker: Hemagglutination inhibition antibody
Type: Surrogate Endpoint (SUR)
Study 15831540 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 7530585 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 15655271 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 15655271 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 8607590 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22550052 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 22550052 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10330958 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 8792953 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 28105731 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 28105731 — Biomarker: Natriuretic peptides A
Type: Safety Biomarker (SAF)
Genes: NPPA; ANP; PND
Study 28105731 — Biomarker: Urokinase plasminogen activator surface receptor
Type: Monitoring Biomarker (MOI)
Genes: PLAUR; MO3; UPAR
Study 23209111 — Biomarker: EBF1 mRNA
Type: Predictive Biomarker (PRD)
Genes: EBF1; COE1; EBF
Study 9447855 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 2757771 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 11978259 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11978259 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 24486732 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19095139 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 19095139 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 19095139 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25410653 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 19496838 — Biomarker: Bacterial count
Type: Surrogate Endpoint (SUR)
Study 1483494 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24657003 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 16087788 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29145839 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 10860192 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9217378 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 24418570 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 18397984 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 16231254 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 10701818 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9347681 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 9347681 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 8516490 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 14626750 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 14626750 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 14626750 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 30040242 — Biomarker: CS mRNA
Type: Predictive Biomarker (PRD)
Genes: CS
Study 20659607 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15834297 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8699839 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 8699839 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 8699839 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 1760713 — Biomarker: LCT mRNA
Type: Predictive Biomarker (PRD)
Genes: LCT; LPH
Study 1760713 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 6291361 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 6291361 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28748386 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 22898037 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study 22898037 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study 22898037 — Biomarker: Vascular endothelial growth factor receptor 2
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY)
Genes: KDR; FLK1; VEGFR2
Study 22898037 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 19398921 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 19398921 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 25509728 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 12861239 — Biomarker: APRT mRNA
Type: Predictive Biomarker (PRD)
Genes: APRT
Study 21565967 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 18461212 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 18461212 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1290019 — Biomarker: Interferon gamma
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: IFNG
Study 30144016 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12151907 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30278430 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 30278430 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 19210039 — Biomarker: Apolipoprotein E
Type: Predictive Biomarker (PRD)
Genes: APOE
Study 19210039 — Biomarker: Microtubule-associated protein tau
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY)
Genes: MAPT; MAPTL; MTBT1; TAU
Study 16580587 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 14508717 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 26578543 — Biomarker: GCKR mRNA
Type: Predictive Biomarker (PRD)
Genes: GCKR
Study 26578543 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 22413836 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 20429947 — Biomarker: GAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAD1; GAD; GAD67
Study 18241758 — Biomarker: Carcinoembryonic antigen CEA
Type: Monitoring Biomarker (MOI)
Genes: CEACAM5; CEA
Study 14613288 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 11549532 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 3415801 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3415801 — Biomarker: Serum testosterone
Type: Surrogate Endpoint (SUR)
Study 16608770 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 16608770 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 7197960 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28334675 — Biomarker: BDNF mRNA
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: BDNF
Study 28334675 — Biomarker: BDNF
Type: Safety Biomarker (SAF)
Study 25987642 — Biomarker: High-frequency oscillations
Type: Pharmacodynamic Biomarker (PDY)
Study 22948968 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 20213082 — Biomarker: PAK1 mRNA
Type: Predictive Biomarker (PRD)
Genes: PAK1
Study 20213082 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 17172317 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 11497194 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31916514 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 31669193 — Biomarker: TLR7 mRNA
Type: Predictive Biomarker (PRD)
Genes: TLR7; UNQ248/PRO285
Study 23499420 — Biomarker: Proto-oncogene c-Met
Type: Predictive Biomarker (PRD)
Genes: MET
Study 14961155 — Biomarker: von Willebrand factor
Type: Safety Biomarker (SAF)
Genes: VWF; F8VWF
Study 14961155 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 14961155 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 24108314 — Biomarker: Serum calcium
Type: Surrogate Endpoint (SUR)
Study 21723949 — Biomarker: EP300 mRNA
Type: Predictive Biomarker (PRD)
Genes: EP300; P300
Study 21723949 — Biomarker: EDA mRNA
Type: Predictive Biomarker (PRD)
Genes: EDA; ED1; EDA2
Study 15546536 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11208863 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 11208863 — Biomarker: Interleukin 10
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL10
Study 29879395 — Biomarker: ARCN1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ARCN1; COPD
Study 23067920 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 18568731 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 31074876 — Biomarker: EP300 mRNA
Type: Predictive Biomarker (PRD)
Genes: EP300; P300
Study 21487089 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 9446265 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 29315686 — Biomarker: Reactive oxygen species
Type: Safety Biomarker (SAF)
Study 18075758 — Biomarker: Hormone receptor
Type: Predictive Biomarker (PRD)
Study 18075758 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 10928462 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 10928462 — Biomarker: Plasminogen activator inhibitor
Type: Safety Biomarker (SAF)
Genes: SERPINE1; PAI1; PLANH1
Study 27898496 — Biomarker: Proto-oncogene c-Met
Type: Predictive Biomarker (PRD)
Genes: MET
Study 27898496 — Biomarker: COMMD3 mRNA
Type: Predictive Biomarker (PRD)
Genes: COMMD3; BUP; C10orf8
Study 23591634 — Biomarker: TNFRSF11B mRNA
Type: Predictive Biomarker (PRD)
Genes: TNFRSF11B; OCIF; OPG
Study 23591634 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 23591634 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1